Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7953)
All Articles published online
|
Publishing Process of This Article
|
Aug 7, 2019 (publication date) through Apr 17, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Meringer H, Shibolet O, Deutsch L. Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm? World J Gastroenterol 2019; 25(29): 3929-3940 [PMID: 31413528 DOI: 10.3748/wjg.v25.i29.3929] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v25/i29/3929.htm |
| Number | Citing Articles |
| 1 |
Marie Gamal, Hatem Tallima, Hassan M. E. Azzazy, Anwar Abdelnaser. Impact of HepG2 Cells Glutathione Depletion on Neutral Sphingomyelinases mRNA Levels and Activity. Current Issues in Molecular Biology 2023; 45(6): 5005 doi: 10.3390/cimb45060318
|
| 2 |
Anna Rossetto, Valli De Re, Agostino Steffan, Matteo Ravaioli, Gianmaria Miolo, Patrizia Leone, Vito Racanelli, Alessandro Uzzau, Umberto Baccarani, Matteo Cescon. Carcinogenesis and Metastasis in Liver: Cell Physiological Basis. Cancers 2019; 11(11): 1731 doi: 10.3390/cancers11111731
|
| 3 |
Elisabeth Digifico, Silvia Balinzo, Cristina Belgiovine. The Dark Side of the Force: When the Immune System Is the Fuel of Tumor Onset. International Journal of Molecular Sciences 2021; 22(3): 1224 doi: 10.3390/ijms22031224
|
| 4 |
Jacopo Baglieri, Cuili Zhang, Shuang Liang, Xiao Liu, Takahiro Nishio, Sara B. Rosenthal, Debanjan Dhar, Hua Su, Min Cong, Jidong Jia, Mojgan Hosseini, Michael Karin, Tatiana Kisseleva, David A. Brenner. Nondegradable Collagen Increases Liver Fibrosis but Not Hepatocellular Carcinoma in Mice. The American Journal of Pathology 2021; 191(9): 1564 doi: 10.1016/j.ajpath.2021.05.019
|
| 5 |
Ying Yang, Feng-Ping Wu, Wen-Jun Wang, Juan-Juan Shi, Ya-Ping Li, Xin Zhang, Shuang-Suo Dang. Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest China. World Journal of Gastroenterology 2019; 25(44): 6551-6560 doi: 10.3748/wjg.v25.i44.6551
|
| 6 |
Ahmet AKTAŞ, Engin ALTİNKAYA. DİREKT ETKİLİ ANTİVİRAL TEDAVİ ALAN KRONİK HEPATİT C HASTALARINDA ALFA FETOPROTEİN SONUÇLARININ DEĞERLENDİRİLMESİ. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi 2021; 23(2): 220 doi: 10.24938/kutfd.869839
|
| 7 |
Said A. Al-Busafi, Khalid AlNaamani. Liver Cancer in the Middle East. 2021; : 259 doi: 10.1007/978-3-030-78737-0_17
|
| 8 |
Vaishaali Natarajan, Camille R. Simoneau, Ann L. Erickson, Nathan L. Meyers, Jody L. Baron, Stewart Cooper, Todd C. McDevitt, Melanie Ott. Modelling T-cell immunity against hepatitis C virus with liver organoids in a microfluidic coculture system. Open Biology 2022; 12(3) doi: 10.1098/rsob.210320
|
| 9 |
Rossella Fasano, Mahdi Abdoli Shadbad, Oronzo Brunetti, Antonella Argentiero, Angela Calabrese, Patrizia Nardulli, Roberto Calbi, Behzad Baradaran, Nicola Silvestris. Immunotherapy for Hepatocellular Carcinoma: New Prospects for the Cancer Therapy. Life 2021; 11(12): 1355 doi: 10.3390/life11121355
|
| 10 |
Yahya Shadi, Bahram Heshmati, Jalal Poorolajal. Interaction between hepatitis B, hepatitis C and smoking in the development of hepatocellular carcinoma: a systematic review and meta-analysis. Journal of Public Health 2024; 46(1): 51 doi: 10.1093/pubmed/fdad214
|
| 11 |
Lauren A. Beste, Pamela Green, Kristin Berry, Pamela Belperio, George N. Ioannou. Hepatitis C–Related Hepatocellular Carcinoma Incidence in the Veterans Health Administration After Introduction of Direct-Acting Antivirals. JAMA 2020; 324(10): 1003 doi: 10.1001/jama.2020.10121
|
| 12 |
Mousumi Khatun, Ranjit Ray, Ratna B. Ray. Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149: 103 doi: 10.1016/bs.acr.2020.10.003
|
| 13 |
Ariel Jaffe, Tamar H. Taddei, Edoardo G. Giannini, Ysabel C. Ilagan‐Ying, Massimo Colombo, Mario Strazzabosco. Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbook. Liver International 2022; 42(12): 2607 doi: 10.1111/liv.15432
|
| 14 |
Nermine Ehsan, Dina Sweed, Maha Elsabaawy. Evaluation of HCV-related liver fibrosis post-successful DAA therapy. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00129-0
|
| 15 |
Joshua P. Kronenfeld, Emily L. Ryon, David Goldberg, Rachel M. Lee, Adam Yopp, Annie Wang, Ann Y. Lee, Sommer Luu, Cary Hsu, Eric Silberfein, Maria C. Russell, Alan S. Livingstone, Nipun B. Merchant, Neha Goel. Disparities in Presentation at Time of Hepatocellular Carcinoma Diagnosis: A United States Safety-Net Collaborative Study. Annals of Surgical Oncology 2021; 28(4): 1929 doi: 10.1245/s10434-020-09156-4
|
| 16 |
David Rial-Crestelo, María Antonia Sepúlveda, Francisco Javier González-Gasca, Paloma Geijo-Martínez, Elisa Martínez-Alfaro, José Ramón Barberá, Miguel Yzusqui, Sonia Casallo, María García, Constanza Muñoz Hornero, Alfredo Espinosa-Gimeno, Miguel Torralba. Does fibrosis really regress in HIV/hepatitis C virus co-infected patients after treatment with direct antiviral agents?. AIDS 2020; 34(3): 427 doi: 10.1097/QAD.0000000000002433
|
| 17 |
Hiromi Chikada, Kinuyo Ida, Yuji Nishikawa, Yutaka Inagaki, Akihide Kamiya. Liver-specific knockout of B cell lymphoma 6 suppresses progression of non-alcoholic steatohepatitis in mice. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-66539-z
|
| 18 |
Patrizia Leone, Antonio Giovanni Solimando, Rossella Fasano, Antonella Argentiero, Eleonora Malerba, Alessio Buonavoglia, Luigi Giovanni Lupo, Valli De Re, Nicola Silvestris, Vito Racanelli. The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment. Vaccines 2021; 9(5): 532 doi: 10.3390/vaccines9050532
|
| 19 |
Takashi Motomura, Sriram Amirneni, Ricardo Diaz-Aragon, Lanuza Faccioli, Michelle Malizio, Michael Coard, Zehra Kocas-Kilicarslan, Carla Frau, Nils Haep, Alina Ostrowska, Rodrigo Florentino, Alejandro Soto-Gutierrez. Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic Target. Journal of Personalized Medicine 2021; 11(7): 619 doi: 10.3390/jpm11070619
|
| 20 |
Ming-Ying Lu, Ming-Lun Yeh, Ching-I Huang, Shu-Chi Wang, Yi-Shan Tsai, Pei-Chien Tsai, Yu-Min Ko, Ching-Chih Lin, Kuan-Yu Chen, Yu-Ju Wei, Po-Yao Hsu, Cheng-Ting Hsu, Tyng-Yuan Jang, Ta-Wei Liu, Po-Cheng Liang, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu. Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication. World Journal of Gastroenterology 2022; 28(1): 140-153 doi: 10.3748/wjg.v28.i1.140
|
| 21 |
François-Loïc Cosset, Chloé Mialon, Bertrand Boson, Christelle Granier, Solène Denolly. HCV Interplay with Lipoproteins: Inside or Outside the Cells?. Viruses 2020; 12(4): 434 doi: 10.3390/v12040434
|
| 22 |
Samira Ben Brahim, Daniel Hartmann, Michael W. Müller, Helmut Friess. Viszerale Operationen bei Patienten mit Leberzirrhose - was ist zu beachten?. Gastro-News 2020; 7(5): 45 doi: 10.1007/s15036-020-1371-0
|